Akebia Therapeutics (AKBA)
NASDAQ:AKBA

Akebia Therapeutics (AKBA) Similar Stocks

1,241 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Akebia Therapeutics
$289.24M
-6.60
19.67%
2 Buy
0 Hold
0 Sell
Moderate Buy
$4.50
BioMarin Pharmaceutical
$16.20B
79.02
-3.41%
12 Buy
6 Hold
0 Sell
Moderate Buy
$106.19
Gilead Sciences
$90.21B
198.41
-4.50%
12 Buy
11 Hold
0 Sell
Moderate Buy
$81.95
Incyte
$14.66B
19.97
3.69%
6 Buy
5 Hold
1 Sell
Moderate Buy
$68.30
Karyopharm Therapeutics
$113.55M
-0.73
-43.56%
4 Buy
1 Hold
0 Sell
Strong Buy
$5.00

Performance Comparison

Ticker
Company Name
Price
$ Change
% Change
AKBA
Akebia Therapeutics
1.46
-0.01
-0.68%
BMRN
BioMarin Pharmaceutical
84.43
-3.40
-3.87%
GILD
Gilead Sciences
71.17
-2.94
-3.97%
INCY
Incyte
65.80
2.01
3.15%
KPTI
Karyopharm Therapeutics
0.92
-0.67
-42.14%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis